Career Enhancement Program

职业提升计划

基本信息

项目摘要

ABSTRACT: Career Enhancement Program (CEP) The mission of the MSCP SPORE Career Enhancement Program (CEP) is to stimulate basic, translational, and clinical research by recruiting and supporting new investigators in the area of melanoma and other skin cancers. The CEP provides financial resources for this mission, while the SPORE itself provides a supportive and stimulating research environment. In the most recent MSCP SPORE grant period, we supported 8 CEP awardees, all of whom were early-stage investigators (2 Instructors, 1 Research Assistant Professor and 5 Assistant Professors). CEP Awardees have experienced success in advancing their careers (with 6 receiving academic promotions and 1 assuming a senior leadership position in industry), publishing their work, and obtaining extramural funding. We will continue to solicit proposals via RFP 1-2 times/year and to use a peer- reviewed scoring system to prioritize proposals for funding (2-3/year at up to $75K each). The CEP and SPORE Co-Directors, RMC representatives, Internal and External Advisory Board members participate in the review process, together with Patient Advocates and additional experts who may be called upon if special reviewer expertise is necessary. The CEP will track progress of the successful applications and provide advisors to funded investigators to ensure that they obtain any needed services from the MSCP SPORE Cores and that they are fully-integrated into the SPORE program. Awardees present their research results to the SPORE investigators after one year of support in order to become eligible for a second year of support. Progress toward translation as well as likely impact and innovation determine whether ongoing CEP projects evolve into future full SPORE projects (as in the case of Projects 1 and 2 in the current application). Awardees will also be advised as appropriate in the preparation of grant applications for funding outside the SPORE mechanism and given access to Core resources to aid in this endeavor.
摘要:职业提升计划(CEP)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Walter J. Storkus其他文献

Cellules dendritiques modifiées et utilisations pour le traitement du cancer
树突状细胞的修饰及其在癌症特性中的应用
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mark Braughler;Prasanna Kumar;Walter J. Storkus;Hideho Okada
  • 通讯作者:
    Hideho Okada
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
  • DOI:
    10.1186/s40425-018-0495-7
  • 发表时间:
    2019-01-09
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Zong Sheng Guo;Binfeng Lu;Zongbi Guo;Esther Giehl;Mathilde Feist;Enyong Dai;Weilin Liu;Walter J. Storkus;Yukai He;Zuqiang Liu;David L. Bartlett
  • 通讯作者:
    David L. Bartlett

Walter J. Storkus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Walter J. Storkus', 18)}}的其他基金

Developmental Research Program
发展研究计划
  • 批准号:
    10683763
  • 财政年份:
    2021
  • 资助金额:
    $ 7.54万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10683764
  • 财政年份:
    2021
  • 资助金额:
    $ 7.54万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10270234
  • 财政年份:
    2021
  • 资助金额:
    $ 7.54万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10469638
  • 财政年份:
    2021
  • 资助金额:
    $ 7.54万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10270235
  • 财政年份:
    2021
  • 资助金额:
    $ 7.54万
  • 项目类别:
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
项目 3:TME 中的趋化因子调节,以增强 TLS 形成和治疗性 CD8 TIL 的交叉引发/招募
  • 批准号:
    10362702
  • 财政年份:
    2020
  • 资助金额:
    $ 7.54万
  • 项目类别:
Induction of Therapeutic Immunity in the Tumor Microenvironment
肿瘤微环境中治疗性免疫的诱导
  • 批准号:
    9079574
  • 财政年份:
    2016
  • 资助金额:
    $ 7.54万
  • 项目类别:
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
针对黑色素瘤相关脉管系统的组合免疫疗法
  • 批准号:
    8720521
  • 财政年份:
    2012
  • 资助金额:
    $ 7.54万
  • 项目类别:
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
针对黑色素瘤相关脉管系统的组合免疫疗法
  • 批准号:
    8548313
  • 财政年份:
    2012
  • 资助金额:
    $ 7.54万
  • 项目类别:
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
针对黑色素瘤相关脉管系统的组合免疫疗法
  • 批准号:
    9111875
  • 财政年份:
    2012
  • 资助金额:
    $ 7.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了